Provided by Tiger Fintech (Singapore) Pte. Ltd.

180 Life Sciences Corp

3.54
+0.26007.93%
Post-market: 3.24-0.3000-8.47%19:59 EDT
Volume:3.33M
Turnover:12.02M
Market Cap:21.38M
PE:-0.23
High:3.57
Open:2.96
Low:2.72
Close:3.28
Loading ...

180 Life Sciences announces upsized $425M PIPE offering

TIPRANKS
·
29 Jul

180 Life Sciences Corp. Announces $425 Million Private Placement to Establish Ethereum Treasury and Rebrand as ETHZilla

Reuters
·
29 Jul

180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch Ethzilla

THOMSON REUTERS
·
29 Jul

180 Life Sciences Corp - Company to Rebrand to Ethzilla Corporation After Closing

THOMSON REUTERS
·
29 Jul

180 Life Sciences Corp. Stockholders Approve New Incentive Plans and Amendments at 2025 Annual Meeting

Reuters
·
25 Jul

180 Life Sciences Q2 EPS $(0.30) Down From $0.01 YoY

Benzinga
·
24 Jul

180 Life Sciences Corp. Accelerates Vesting of Executive Compensation Awards Under 2025 Plan

Reuters
·
15 Jul

180 Life Sciences Corp. Strengthens IP Portfolio with New Patent Allowances for Fibrotic Disorders and Neuroinflammation

Reuters
·
01 Jul

180 Life Sciences Files $500 Million Shelf Registration With SEC

MT Newswires Live
·
21 Jun

180 Life Sciences Corp. Awards Stock Options to Executives and Directors in Private Placement

Reuters
·
21 Jun

180 Life Sciences files $500M mixed securities shelf

TIPRANKS
·
21 Jun

BRIEF-180 Life ScienceS files for mixed shelf of up to $500 mln – SEC Filing

Reuters
·
21 Jun

180 Life Sciences Corp. Announces Board Resignation and New Incentive Plan Adoption

Reuters
·
19 Jun

180 Life Sciences Gets Notice of Allowance for Method to Prevent POCD

MT Newswires Live
·
02 May

180 Life Sciences announces notice of allowance for U.S. patent

TIPRANKS
·
01 May

180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction

ACCESS Newswire
·
01 May

180 Life Sciences Corp. Announces Share Repurchase

ACCESS Newswire
·
30 Apr